Introduction
Computed tomography angiography (CTA) is a simple and noninvasive procedure for the evaluation of the hepatic vasculature. Although conventional angiography can also provide assessment of the hepatic vasculature, the modality is invasive and more technically difficult to perform than CTA. CTA is replacing conventional angiography in the depiction of the normal vascular anatomy and the diagnosis of vascular disorders [
10]. However, CTA two-dimensional (2D) images do not provide complete three-dimensional images of the hepatic vascular anatomy. As three-dimensional (3D) reconstruction provides more comprehensive and accurate anatomic information, 3D CTA is a useful method to improve the limitations of the use of 2D images.
Three-dimensional CTA represents an increasingly important clinical tool that is used to diagnose portal hypertension and hepatic vascular disorders. These disorders include the presence of a single or multiple extrahepatic portosystemic shunt, intrahepatic portosystemic shunt, portal vein thrombosis, intravascular tumor extension, and well-developed vascular tumors such as a hepatocellular carcinoma, liver or pancreatic neoplasia. Three-dimensional CTA is also used to evaluate suspected liver disease, and is used for surgical planning [
1,
3,
9,
11].
In veterinary medicine, CT portography has been performed in normal dogs and in veterinary subjects with portosystemic shunts [
3] to develop the dual-phase CT angiography technique for normal dogs [
11]. However, methods of 3D reconstruction and 3D CTA analysis for the canine hepatic vasculature have not been investigated. The objectives of this study are 1) to develop the CTA technique for imaging of the canine hepatic vasculature and 2) to describe the anatomy of the hepatic vasculature with the use of 3D CTA.
Materials and Methods
Animals
Eight healthy Beagle dogs, ranging from 1 to 4 years old and weighing 6 to 12 kg were used in the study. A 22 G indwelling catheter was placed in a cephalic vein and was connected to a CT power injector (LF CT9000 ADV; Liebel-Flarsheim, USA) by an extension line (Control pressure line; Hyup Sung Medical, Korea).
Contrast media
Non-ionic iodine contrast media, iohexol (Omnipaque 300 mg Iodine/ml; Amersham Health, UK) was used for cine scans and for enhanced scans. Contrast media was injected by the use of a CT power injector and all injection rates were 2.0 ml/sec.
Helical CT scaning and parameters
CT angiography was performed using a single slice helical CT scanner (GE CT/e; GE Healthcare, USA). The CT programs for image analysis were as follows. 1) The use of cine CT; 2) the use of a retrospective reconstruction program; 3) the use of a reformatted program (for axial, sagittal, transverse and oblique plane images); 4) the use of a cross section histogram for measurement of Hounsfield units (HU) in the 2D plane; 5) the use of a 3D display of shaded surface display (SSD) and maximum intensity projection (MIP).
Experimental animal preparation for CT scanning
General anesthesia was performed to avoid motion artifacts and breath holding was induced by hyperventilation. The position of the animals was dorsal recumbency and the heads of the dogs were placed toward the CT gantry.
Experimental design
Unenhanced scan: Unenhanced scans were performed to determine the location of the cine scan, the scan field range of the enhanced scan and to measure pre-contrast HU values of the aorta (AO), caudal vena cava (CVC), portal vein (PV) and liver. Conditions included a 5 mm thickness, 3 mm interval, 1.5 pitch, 120 kVp and 40~60 mA in each animal. Scans were started from the cranial aspect of the diaphragm to the caudal aspect of the fourth lumbar vertebra. After the unenhanced scan was performed, the cine scan location, scan field range of the enhanced scan and pre-contrast HU values of each vessel and the liver at the cine scan location were determined.
Cine scan: In the cine scan, operating conditions of a 3 mm thickness, 120 kVp, 30~55 mA, 1.5 sec per rotation scan speed and 50 serial axial images for 78 sec were performed. The cine scan was performed at the site of the well visualized AO, CVC, PV and liver at the thirteenth thoracic vertebra level. This scan was performed in order to obtain time-attenuation curves of the injected iohexol (0.5 ml/kg). With the use of time-attenuation curves, the delay time for helical CT acquisition was obtained. Time-attenuation curves of the AO, CVC and PV were achieved by using a hardwired basic CT program on the CT unit (
Fig. 1).
Enhanced scan: The enhanced scan was divided into the arterial phase and the venous phase. Arterial phase images were obtained by caudocranial data acquisition and venous phase images were obtained by craniocaudal acquisition to minimize time during the dual phase scan. The enhanced scan was performed by using the following parameters of a 5 mm thickness, 5 mm interval, 120 kVp, 40~60 mA and 1.3~1.5 pitch. Time-attenuation data were used to optimize the delay of CTA image acquisition following IV injection of contrast medium to maximize hepatic vessel opacification. A delay time was applied to arterial phase scanning. The venous phase was started directly after the arterial phase scan termination. The contrast medium dose used was 3 ml/kg. All enhanced phase data were reconstructed to 1 mm interval images retrospectively.
Statistical analysis
Statistical analysis was performed by the use of SPSS software (SPSS 12.0.0; SPSS, Chicago, IL USA). A one-way ANOVA least significant difference test was applied for quantitative data analysis. The Kruskal-Wallis test and Mann-Whitney U test were applied for qualitative data analysis [
1,
2].
Discussion
Imaging methods for the hepatic vasculature include conventional angiography, ultrasonography, and CTA. Conventional angiography for the hepatic vasculature can provide good vascular images. However, the use of the modality is invasive to patients, has a relatively high cost as compared to other methods [
6], requires a difficult technique of superselective catheterization for the hepatic arteries [
8] and is time consuming. Ultrasound is an expedient method for imaging of the hepatic vasculature, but disadvantages include the disparity of accuracy between sonographers [
3] and many factors such as bone, gas and fat that can interfere with the transmission of the ultrasound beam [
2].
CTA provides a fast, noninvasive modality for the evaluation of the hepatic vasculature. The use of a helical CT scan with the advanced 3D display technique provides detailed anatomic images of the hepatic vasculature and requires little time. It is also less than one-third the cost of conventional angiography, and is not dependent on the skill of the operator performing the study or on the body habitus of the patient [
6].
The most important parameter of the hepatic CTA was the 'time delay' between the injection of contrast medium and image acquisition. When the delay time is applied to a scan, it permits scanning during maximal enhancement. In this study, the optimal delay time was set at 9 sec in the arterial phase and at 18 sec in the venous phase. This protocol offered good vascular enhancement.
Although the venous delay time was set at 18 sec by the use of a cine scan, the actual real venous phase scan started at 20 sec later for the ideal venous delay time. This was due to the contrast medium injection delay time, the time required for arterial phase scanning and the scan delay in the CT scanner itself between arterial phase scanning and venous phase scanning. In spite of this retardation, it did not affect the image quality.
In all phases of the CT scan, vascular HU values increased as much as the contrast media dose increased. During the arterial phase, there were patterns of increasing vascular HU values, but there was no statistical difference in the HU values despite the dose increase. It was deduced that the opacified difference related to contrast dose did not appear prominent as arteries have characteristics of fast opacifying, deopacifying after contrast media injection and have a relatively smaller size than veins. In the venous phase, there were remarkable opacified differences that were seen related to contrast dosage.
In most CT angiography procedures in humans, an injection rate of various iodine concentrations is used in a range of 1.5~5 ml/sec [
3]. For arterial 3D construction, 5 ml/sec is necessary to achieve a greater intravascular concentration and therefore a higher CT attenuation. Since aberrant hepatic arteries can be relatively small, they need to show sufficient enhancement so that they are not obscured during 3D threshold-based reconstruction [
5]. However, in the portal and venous phase, the effect of bolus injection is gradually diminished and a higher injection rate causes a narrow "temporal window" (duration of optimal enhancement) [
3]. As these factors and with a single channel helical CT limitation, although the arterial bolus effect was decreased, a rate of 2 ml/sec was chosen in this study as the injection rate.
With the use of the MIP technique, vascular anatomy is best depicted when there is a large difference between the attenuation values of vessels opacified by use of contrast agent and the surrounding tissues. However, MIP lacks depth orientation, and the technique is not as capable to display complex anatomy, especially when overlapping vessels are present [
10].
Traditional helical single-slice CT scanners are still limited in the ability to image large volumes during a single breathhold and to provide adequate spatial resolution crucial for CT angiography [
6]. In this study, due to the limitation of the use of a single channel helical CT scanner, a wide slice thickness and narrow scan range including the liver and the full vascular structures was used. This limitation has prompted the development of faster multidetector helical CT scanners (MDCT) that can cover an extensive volume quickly with excellent spatial resolution [
6]. The use of MDCT can overcome the limitations of hepatic CTA that occur with the use of a single channel CT scanner.
In conclusion, 3D CTA has been shown as a useful method for the evaluation of the canine hepatic vasculature.